Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
Launched by JOHNS HOPKINS UNIVERSITY · Aug 5, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how to better understand and diagnose retinal vascular diseases, which are conditions affecting the blood vessels in the eye, like diabetic retinopathy and retinal vein occlusion. Researchers will compare images and clinical findings from healthy individuals and those with these eye diseases to identify changes in disease stages. The goal is to see how these conditions progress or improve with standard treatments over time.
To take part in this study, participants need to be between the ages of 36 and 159, and both men and women can join. However, children, pregnant women, and individuals with certain eye or health conditions, such as glaucoma or significant heart disease, are not eligible. If you join, you can expect to undergo various tests and imaging to help researchers gather important information about your eye health. Your participation could help improve how doctors diagnose and treat these conditions in the future.
Gender
ALL
Eligibility criteria
- Exclusion Criteria:
- * Both subjects with diseases and controls:
- • Children (age\<18)
- • Pregnant females
- • Developmentally delayed subjects
- • Subjects unable to provide informed consent
- • Inability to cooperate with tests and study instructions
- • Images with motion artifact or signal strength \< 7
- • History of glaucoma
- • History of age-related macular degeneration
- • History of any visually significant eye disease
- • History of proliferative diabetic retinopathy
- • History of any inflammatory disease
- • History of heart disease
- • History of thyroid disease.
- * Additional criteria for controls:
- • History of any type of Diabetes Mellitus
- • History of any type of Hypertension
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Patients applied
Trial Officials
Amir Kashani, MD, MPH
Principal Investigator
Johns Hopkins University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials